Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O. Hexner, Robert S. Hoffman, Jill Kleczko et al.|Leukemia & lymphoma/Leukemia and lymphoma|2015Cited by 34
A Phase II Trial Of Epigenetic Modulators Vorinostat In Combination With Azacitidine (azaC) In Patients With The Myelodysplastic Syndrome (MDS): Initial Results Of Study 6898 Of The New York Cancer ConsortiumLewis R. Silverman, Richard Piekarz, Amit Verma et al.|Blood|2013Cited by 27
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with MyelofibrosisDamiano Rondelli, Robert S. Hoffman, Judith D. Goldberg et al.|Transplantation and Cellular Therapy|2012Cited by 10
Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with MyelofibrosisDamiano Rondelli, Robert S. Hoffman, Judith D. Goldberg et al.|Blood|2011Cited by 3
Establishing a Pathogenic Role for NK Cells As Drivers of Bone Marrow Failure in the Myelodysplastic Syndromes (MDS)Richa Rai, Amir Horowitz, Jonathan Feld et al.|Blood|2023Cited by 0